Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

olaratumab

olaratumab
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Lartruvo SOLUTION, INTRAVENOUS 10 mg/mL      
Comments:

Restricted to oncology use in outpatient setting. Each case should be evaluated for obtaining drug from specialty wholesaler or patient specific supply from specialty pharmacy.

Reviewed: 25 July 2017 (Lartruvo)

Last updated: Jul. 31, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved